Atlas Trials

An Observational Study to Assess the Canagliflozin Treatment in Type 2 Diabetes Mellitus in a Usual Clinical Practice in Canada

Clinical trial NCT02688075 · COMPLETED

Trial details

NCT number
NCT02688075
Sponsor
Janssen Inc.
Status
COMPLETED
Study type
OBSERVATIONAL
Diabetes Mellitus, Type 2
Start date
2015-11-13
Primary completion
2017-08-17
Enrollment
538

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.